Log In
Print this Print this

pTVG-AR (MVI-118)

  Manage Alerts
Collapse Summary General Information
Company Madison Vaccines Inc.
DescriptionPlasmid DNA vaccine carrying the ligand binding domain of the human androgen receptor
Molecular Target Androgen receptor
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat metastatic prostate cancer; Treat non-metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today